Pubblicazioni

Totale pubblicazioni a partire dal 2011: 367


Anno

2019; 10(1): 69-75

Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice.

Panebianco C, Eddine FBN, Forlani G, Palmieri G, Tatangelo L, Villani A, Xu L, Accolla R, Pazienza V


2018; 14(5): e1007329

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS


2018; 39(4): 448-453

Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance - A Multi-Center Study.

Francica G, Meloni MF, de Sio I, Terracciano F, Caturelli E, Riccardi L, Roselli P, Iadevaia MD, Scaglione M, Lenna G, Chiang J, Pompili M


2018; ():

Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study.

Viola A, Pugliese D, Renna S, Furfaro F, Caprioli F, D'Incà R, Bossa F, Mazza S, Costantino G, Fantini M, Fiorino G, Alibrandi A, Orlando A, Armuzzi A, Fries W


2018; 8(1): 16389

Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer.

Tavano F, Gioffreda D, Valvano MR, Palmieri O, Tardio M, Latiano TP, Piepoli A, Maiello E, Pirozzi F, Andriulli A


Sherlock’s Diseases of the Liver and Biliary System, Thirteenth Edition. Edited by James S. Dooley, Anna S. F. Lok, 2018; :

Sherlock's Diseases of the Liver and Biliary System, 13th Edition

Farci P., Niro G.

2018; 10(): 75

Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease.

Klasić M, Markulin D, Vojta A, Samaržija I, Biruš I, Dobrinić P, Ventham NT, Trbojević-Akmačić I, Šimurina M, Štambuk J, Razdorov G, Kennedy NA, Satsangi J, Dias AM, Pinho S, Annese V, Latiano A, D'Inca R, IBD consortium., Lauc G, Zoldoš V


2018; 6(1): 92

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Panebianco C, Andriulli A, Pazienza V


2018; 19(10):

Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.

Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, Sgrulletti M, Salerno G, Terracciano F, D'Amelio R, Laganà B, Pazienza V


2018; 56(9): 1400-1412

Exploring the microbiota to better understand gastrointestinal cancers physiology.

Panebianco C, Potenza A, Andriulli A, Pazienza V


2018; 105(): 96-101

Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study.

Francica G, Meloni MF, Riccardi L, de Sio I, Terracciano F, Caturelli E, Iadevaia MD, Amoruso A, Roselli P, Chiang J, Scaglione M, Pompili M


2018; 9(1): 556

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Br


2018; 155(1): 168-179

Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.

Bonfiglio F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, Bujanda L, Bresso F, Agreus L, Andreasson A, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M


2018; 9(1): 2427

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

Momozawa Y, Dmitrieva J, Théâtre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori AS, Lecut C, Mariman R, Mni M, Oury C, Altukhov I, Alexeev D, Aulchenko Y, Amininejad L, Bouma G, Hoentjen F, Löwenberg M, Oldenburg B, P


2018; 6(2): 225-237

Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A, ITAL-C consortium.


2018; 12(6): 687-694

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.

Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D, ATTICA Study Group by the Grupo Español de T


2018; 155(3): 829-843

Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.

Clerc F, Novokmet M, Dotz V, Reiding KR, de Haan N, Kammeijer GSM, Dalebout H, Bladergroen MR, Vukovic F, Rapp E, IBD-BIOM Consortium., Targan SR, Barron G, Manetti N, Latiano A, McGovern DPB, Annese V, Lauc G, Wuhrer M


2018; ():

Unmet needs of Italian physicians managing patients with inflammatory bowel disease.

Bezzio C, Imperatore N, Armuzzi A, Rizzello F, Manes G, Bossa F, Calabrese E, Caprioli F, Daperno M, Mocciaro F, Orlando A, Papi C, Rispo A, Saibeni S, Italian Group for Inflammatory Bowel Disease (IG-IBD).


2018; 154(5): 1320-1333.e10

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M, Inflammatory Bowel Disease Biomarkers Consortium., McGovern DPB, A


2018; 30(6): 676-681

Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.

Sagnelli E, Stroffolini T, Sagnelli C, Cacopardo B, Andriulli A, Babudieri S, Coppola N, Gaeta GB, Almasio PL


2018; 53(): 79-84

Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.

Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M


2018; ():

Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

Kondili LA, Robbins S, Blach S, Gamkrelidze I, Zignego AL, Brunetto MR, Raimondo G, Taliani G, Iannone A, Russo FP, Santantonio TA, Zuin M, Chessa L, Blanc P, Puoti M, Vinci M, Erne EM, Strazzabosco M, Massari M, Lampertico P, Rumi MG, Federico A, Orlandi


2018; ():

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni


2018; ():

Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study.

Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Ca


2018; ():

The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.

Stroffolini T, Sagnelli E, Sagnelli C, Smedile A, Furlan C, Morisco F, Coppola N, Andriulli A, Almasio PL


2018; (): 1-17

Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.

Lo Re O, Douet J, Buschbeck M, Fusilli C, Pazienza V, Panebianco C, Castracani CC, Mazza T, Li Volti G, Vinciguerra M


Gastroenterology & Hepatology 2018; 14(6): 342-351

Current and Future Management of Chronic Hepatitis D

Farci P, Niro GA


journal of pediatric disorders and neonatal care 2018; vol.1 (1):

Does the opening of a milk bank in NICU cancel the incidence of NEC

Quitadamo PA, Palumbo G, Villani A, Savastano M, Ravidà D, Bisceglia M, Gentile A and Cristalli P.

2018; 81(4): 773-782

Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice.

Panebianco C, Adamberg K, Jaagura M, Copetti M, Fontana A, Adamberg S, Kolk K, Vilu R, Andriulli A, Pazienza V


2018; ():

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Liço V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantù C, Malecka-Panas E, Landi S,


2017; 8(62): 105320-105339

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

Mazza T, Copetti M, Capocefalo D, Fusilli C, Biagini T, Carella M, De Bonis A, Mastrodonato N, Piepoli A, Pazienza V, Maiello E, di Mola FF, di Sebastiano P, Andriulli A, Tavano F


2017; ():

Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F


2017; 153(2): 550-565

Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.

Yadav P, Ellinghaus D, Rémy G, Freitag-Wolf S, Cesaro A, Degenhardt F, Boucher G, Delacre M, International IBD Genetics Consortium., Peyrin-Biroulet L, Pichavant M, Rioux JD, Gosset P, Franke A, Schumm LP, Krawczak M, Chamaillard M, Dempfle A, Andersen V


2017; 49(2): 269-273

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Got


2017; 18(1): 94

Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.

Chen GB, Lee SH, Montgomery GW, Wray NR, Visscher PM, Gearry RB, Lawrance IC, Andrews JM, Bampton P, Mahy G, Bell S, Walsh A, Connor S, Sparrow M, Bowdler LM, Simms LA, Krishnaprasad K, International IBD Genetics Consortium., Radford-Smith GL, Moser G


2017; 547(7662): 173-178

Fine-mapping inflammatory bowel disease loci to single-variant resolution.

Huang H, Fang M, Jostins L, Umicevic Mirkov M, Boucher G, Anderson CA, Andersen V, Cleynen I, Cortes A, Crins F, D'Amato M, Deffontaine V, Dmitrieva J, Docampo E, Elansary M, Farh KK, Franke A, Gori AS, Goyette P, Halfvarson J, Haritunians T, Knight J, La


Annals of translational medicine 2017; 5(21): 429

Fasting and engineered diets as powerful tool in the medical practice: an old approach in the new era.

Panebianco C, Potenza A, Pazienza V


2017; ():

Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Sagnelli E, Stroffolini T, Sagnelli C, Pirisi M, Babudieri S, Colloredo G, Russello M, Coppola N, Gaeta GB, Cacopardo B, De Luca M, Almasio PL, EPACRON study group.


2017; 12(11): e0185710

Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.

Stroffolini T, Sagnelli E, Andriulli A, Colloredo G, Furlan C, Gaeta GB, Morisco F, Pirisi M, Rosina F, Sagnelli C, Smedile A, Almasio PL, EPACRON study group.


2017; ():

Hepatitis C Virus Clearance in Older Adults.

Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A


Annals of gastroenterology. 2017; 30(1): 96-100

Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study.

Guarini A, Biagini S, Capaldi A, Carretto D, Angelis A, Iudice S, Martino G, Marziali B, Mattiola R, Ongarelli C, Onidi FM, Prinzio M, Puthiavettil R, Sardi R, Schiavoni E, Sinatora R, Zullo A


2017; ():

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, W


2017; ():

Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers.

Panebianco C, Kelman E, Vene K, Gioffreda D, Tavano F, Vilu R, Terracciano F, Pata I, Adamberg K, Andriulli A, Pazienza V


2017; 26(8): 1349-1351

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.

Campa D, Obazee O, Pastore M, Panzuto F, Liço V, Greenhalf W, Katzke V, Tavano F, Costello E, Corbo V, Talar-Wojnarowska R, Strobel O, Zambon CF, Neoptolemos JP, Zerboni G, Kaaks R, Key TJ, Lombardo C, Jamroziak K, Gioffreda D, Hackert T, Khaw KT, Landi


World J Gastrointest Pharmacol Ther 2017; 8(2): 131-136

Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study.

Viola A, Costantino G, Privitera AC, Bossa F, Lauria A, Grossi L, Principi MB, Della Valle N, Cappello M


2017; 49(2): 228-229

Screening and treatment of portal vein thrombosis in cirrhosis.

Senzolo M, Simioni P, Andriulli A


2017; 29(9): 994-997

Etiological factors of chronic hepatitis in Italy: a 2014 national survey.

Stroffolini T, Sagnelli E, Almasio PL, Andriulli A, Smedile A, Pirisi M, Sagnelli C, Russello M, Coppola N, de Luca M, Pisaturo M, Rosina F, Gaeta GB, EPACRON study group.


2017; 46(1): 77

Letter: the efficacy of interferon-free regimens in HCV-related Child C cirrhosis needs careful interpretation-Authors' reply.

Andriulli A, Guarino M, Morisco F


2017; ():

Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.

Sagnelli E, Stroffolini T, Sagnelli C, Morisco F, Coppola N, Smedile A, Pisaturo M, Colloredo G, Babudieri S, Licata A, Brancaccio G, Andriulli A, Almasio PL, Gaeta GB, EPACRON study group.


2017; 49(10): 1110-1114

Nurse in patients' health status assessment: Data from a pilot study assessing agreement among nurse and gastroenterologist in computing IBD-clinical scores.

Mocciaro F, Pecoraro GM, Di Mitri R, Scimeca D, Bossa F, Russo G, Martino G, Costanza V, Profita MA, Orlando C, Profeta G, Tinè F


2017; 41(4): 435-444

Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes.

Russo E, Lombardelli L, Giudici F, Cavalli T, Ficari F, Fazi M, Scaringi S, Biancone L, Logiodice F, Nesi M, Latiano A, Annese V, Torcia MG, Bechi P, Tonelli F, Piccinni MP, Malentacchi C


2017; 7(): 43812

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.

Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, V


2017; 17(1): 104

Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.

Barontini J, Antinucci M, Tofanelli S, Cammalleri M, Dal Monte M, Gemignani F, Vodicka P, Marangoni R, Vodickova L, Kupcinskas J, Vymetalkova V, Forsti A, Canzian F, Stein A, Moreno V, Mastrodonato N, Tavano F, Panza A, Barale R, Landi S, Campa D


2017; 49(4): 338-358

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizze


2017; 11(5): 556-561

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists.

Daperno M, Comberlato M, Bossa F, Armuzzi A, Biancone L, Bonanomi AG, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Grassano L, Pagana G, D'Incà R, Orlando A, Rizzello F, IGIBDEndo Group.


2017; 45(3): 481-482

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.

Niro GA, Smedile A, Andriulli A, Rizzetto M


2017; 262(): 179-184

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.

Angelico F, Corradini SG, Pastori D, Fargion S, Fracanzani AL, Angelico M, Bolondi L, Tozzi G, Pujatti PL, Labbadia G, Corazza GR, Averna M, Perticone F, Croce G, Persico M, Bucci T, Baratta F, Polimeni L, Del Ben M, Violi F, LAL-Cirrhosis Collaborative R


2017; 23(2): 233-243

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, D'Incà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, A


2017; 45(9): 1193-1200

Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.

Guarino M, Morisco F, Valvano MR, Ippolito AM, Librandi M, Andriulli N, Greco M, Amoruso A, Iacobellis A, Niro G, Caporaso N, Andriulli A


2017; 49(9): 1022-1028

HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fon


2017; ():

A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study.

Barone M, Iannone A, Shahini E, Ippolito AM, Brancaccio G, Morisco F, Milella M, Messina V, Smedile A, Conti F, Gatti P, Santantonio T, Tundo P, Lauletta G, Napoli N, Masetti C, Termite AP, Francavilla R, Di Leo A, Pesce F, Andriulli A


2017; ():

Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.

Campa D, Pastore M, Capurso G, Hackert T, Di Leo M, Izbicki JR, Khaw KT, Gioffreda D, Kupcinskas J, Pasquali C, Macinga P, Kaaks R, Stigliano S, Peeters PH, Key TJ, Talar-Wojnarowska R, Vodicka P, Valente R, Vashist YK, Salvia R, Papaconstantinou I, Shimi


2017; 8(): 1157

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation.

Pindjakova J, Sartini C, Lo Re O, Rappa F, Coupe B, Lelouvier B, Pazienza V, Vinciguerra M


2017; 8(25): 41265-41281

Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.

Tataranni T, Agriesti F, Ruggieri V, Mazzoccoli C, Simeon V, Laurenzana I, Scrima R, Pazienza V, Capitanio N, Piccoli C


2017; ():

Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.

Lo Re O, Panebianco C, Porto S, Cervi C, Rappa F, Di Biase S, Caraglia M, Pazienza V, Vinciguerra M


2017; 18(7):

Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.

Palmieri O, Creanza TM, Bossa F, Latiano T, Corritore G, Palumbo O, Martino G, Biscaglia G, Scimeca D, Carella M, Ancona N, Andriulli A, Latiano A


2017; 9(4):

Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models.

Panebianco C, Adamberg K, Adamberg S, Saracino C, Jaagura M, Kolk K, Di Chio AG, Graziano P, Vilu R, Pazienza V


2017; 12(1): e0168821

Crohn's Disease Localization Displays Different Predisposing Genetic Variants.

Palmieri O, Bossa F, Valvano MR, Corritore G, Latiano T, Martino G, D'Incà R, Cucchiara S, Pastore M, D'Altilia M, Scimeca D, Biscaglia G, Andriulli A, Latiano A


OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY 2016; 20(12): 692-698

Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.

Palmieri O, Mazza T, Castellana S, Panza A, Latiano T, Corritore G, Andriulli A, Latiano A


2016; ():

Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, Siena D, Caruso M, Ippolito A, Mannuccio PM, Andriulli A


2016; 6(): 39565

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.

Campa D, Capurso G, Pastore M, Talar-Wojnarowska R, Milanetto AC, Landoni L, Maiello E, Lawlor RT, Malecka-Panas E, Funel N, Gazouli M, De Bonis A, Klüter H, Rinzivillo M, Delle Fave G, Hackert T, Landi S, Bugert P, Bambi F, Archibugi L, Scarpa A, Katzke


2016; :

Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier

Palmieri O., Mazza T., Castellana S., Panza A., Latiano T., Corritore G., Andriulli A., Latiano A.

2016; 7(): 13507

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.

Ventham NT, Kennedy NA, Adams AT, Kalla R, Heath S, O'Leary KR, Drummond H, IBD BIOM consortium., IBD CHARACTER consortium., Wilson DC, Gut IG, Nimmo ER, Satsangi J


2016; :

A Polymorphism of the Tnf-? Gene Promotes Steroid-Resistance In patients with Inflammatory Bowel Disease

Palmieri O., Latiano A., Bossa F., Valvano M.R., D'incà R., Corritore G., Latiano T., Andriulli A., Annese V.

2016; ():

Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.

Stroffolini T, Sagnelli E, Gaeta GB, Sagnelli C, Andriulli A, Brancaccio G, Pirisi M, Colloredo G, Morisco F, Furlan C, Almasio PL, EPACRON study group.


2016; ():

Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis Pain.

Iacobellis A, Seripa D, Palmieri O, Andriulli N, Latina P


2016; ():

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists.

Daperno M, Comberlato M, Bossa F, Armuzzi A, Biancone L, Bonanomi AG, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Grassano L, Pagana G, D'Incà R, Orlando A, Rizzello F, IGIBDEndo Group.


2016; ():

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".

Fries W, Viola A, Manetti N, Frankovic I, Pugliese D, Monterubbianesi R, Scalisi G, Aratari A, Cantoro L, Cappello M, Samperi L, Saibeni S, Casella G, Mocci G, Rea M, Furfaro F, Contaldo A, Magarotto A, Calella F, Manguso F, Inserra G, Privitera AC, Princ


2016; 9(): 45

Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis.

Pazienza V, Panebianco C, Rappa F, Memoli D, Borghesan M, Cannito S, Oji A, Mazza G, Tamburrino D, Fusai G, Barone R, Bolasco G, Villarroya F, Villarroya J, Hatsuzawa K, Cappello F, Tarallo R, Nakanishi T, Vinciguerra M


XLI Congresso Nazionale AIEOP – Verona, 22-24 maggio 2016 2016; : 89

APPROCCIO MULTIDISCIPLINARE PER UNA GRAVE PANCREATITE ACUTA CON PSEUDOCISTI PANCREATICA IN CORSO DI TERAPIA PER LEUCEMIA LINFOBLASTICA ACUTA AD ALTO RISCHIO

Foglia M., Spirito A., Maruzzi M., Miglionico L., De Santis R., Ciliberti A., Maggio A., Lapolla R., Romaniello L., Sacco E., Parracino T., Gentile M., Pettoello-Mantovani M., LAdogana S.

35 Congresso Nazionale SICT Roma 2016 2016; :

Acalasia esofagea: "Current trends" e ipotesi terapeutiche per il futuro

Cuttitta A., Merla A., Latiano A., Palladino D., Del Naja C., Bizzarri M., Taurchini M.

2016; ():

Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Panebianco C, Oben JA, Vinciguerra M, Pazienza V


2016; (): 1-12

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.

Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, Lo Re O, Peyrou M, Villarroya F, Pazienza V, Rappa F, Cappello F, Azab M, Taverna P, Vinciguerra M


2016; ():

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.

Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats


2016; 65(3): 465-6

Myrcludex B, a novel therapy for chronic hepatitis D?

Rizzetto M, Niro GA


2016; ():

Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.

Rizzato C, Campa D, Talar-Wojnarowska R, Halloran C, Kupcinskas J, Butturini G, Mohelníková-Duchonová B, Sperti C, Tjaden C, Ghaneh P, Hackert T, Funel N, Giese N, Tavano F, Pezzilli R, Pedata M, Pasquali C, Gazouli M, Mambrini A, Soucek P, di Sebastia


2016; ():

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bas Bueno-de-Mesquita H, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks


World journal of hepatology 2016; 8(22): 949-56

Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

Cleo Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D'Adamo G, D'Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Gia


2016; 6(): 31549

Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.

Palmieri O, Mazza T, Merla A, Fusilli C, Cuttitta A, Martino G, Latiano T, Corritore G, Bossa F, Palumbo O, Muscarella LA, Carella M, Graziano P, Andriulli A, Latiano A


2016; 28(4): 581-91

Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation.

Neri L, Iovino P, Laxative Inadequate Relief Survey (LIRS) Group


2016; ():

The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.

Salerno F, Borzio M, Pedicino C, Simonetti R, Rossini A, Boccia S, Cacciola I, Burroughs AK, Manini MA, La Mura V, Angeli P, Bernardi M, Dalla Gasperina D, Dionigi E, Dibenedetto C, Arghittu M, AISF Investigators


Alimentary pharmacology and therapeutics 2016; ():

HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M


2016; ():

Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.

Violi F, Corazza RG, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S, PRO-LIVER Collaborators


2016; ():

Discontinuation of Infliximab in Patients With Ulcerative Colitis is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.

Fiorino G, Cortes PN, Ellul P, Felice C, Karatzas P, Silva M, Lakatos PL, Bossa F, Ungar B, Sebastian S, Furfaro F, Karmiris K, Katsanos KH, Muscat M, Christodoulou DK, Maconi G, Kopylov U, Magro F, Mantzaris GJ, Armuzzi A, Boscà-Watts MM, Ben-Horin S, Bo


2016; ():

Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.

Mazzoccoli G, Colangelo T, Panza A, Rubino R, Tiberio C, Palumbo O, Carella M, Trombetta D, Gentile A, Tavano F, Valvano MR, Storlazzi CT, Macchia G, De Cata A, Bisceglia G, Capocefalo D, Colantuoni V, Sabatino L, Piepoli A, Mazza T


2016; ():

Transperineal ultrasonography: First level exam in IBD patients with perianal disease.

Terracciano F, Scalisi G, Bossa F, Scimeca D, Biscaglia G, Mangiacotti M, Valvano MR, Perri F, Simeone A, Andriulli A


2016; ():

Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer.

Mazza T, Mazzoccoli G, Fusilli C, Capocefalo D, Panza A, Biagini T, Castellana S, Gentile A, De Cata A, Palumbo O, Stallone R, Rubino R, Carella M, Piepoli A


2016; ():

Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis.

Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campennì A, Cannavò S, Trimarchi F, Ruggeri RM


2016; ():

Clock genes-dependent acetylation of complex I sets rhythmic activity of mitochondrial OxPhos.

Cela O, Scrima R, Pazienza V, Merla G, Benegiamo G, Augello B, Fugetto S, Menga M, Rubino R, Fuhr L, Relógio A, Piccoli C, Mazzoccoli G, Capitanio N


2016; ():

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)


2016; 43(1): 174-5

Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma.

Bossa F, Perri F, Niro G, Parente P, Graziano P, Andriulli A


2016; ():

Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites.

Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A, Vrhovsek U, Pazienza V


2016; ():

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.

Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, Han B, Park YR, Raychaudhuri S, Pouget JG, Hübenthal M, Folseraas T, Wang Y, Esko T, Metspalu A, Westra HJ, Franke L, Pers TH, Weersma RK, Collij V, D'Amato M, Halfvarson J, Jensen AB, Lieb W, Degenh


2016; ():

The HLA-DQ?1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans.

Becker J, Haas SL, Mokrowiecka A, Wasielica-Berger J, Ateeb Z, Bister J, Elbe P, Kowalski M, Gawron-Kiszka M, Majewski M, Mulak A, Janiak M, Wouters MM, Schwämmle T, Hess T, Veits L, Niebisch S, Santiago JL, de León AR, de la Serna JP, Urcelay E, Annese V


2016; ():

Infliximab Reduces Endoscopic, but not Clinical, Recurrence of Crohn's Disease Following Ileocolonic Resection.

Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P, PREVENT Study Group


2016; 45(4): 626-9

Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome.

Tavano F, Copetti M, Piepoli A, Carella M, Gentile A, Burbaci FP, Fontana A, De Bonis A, di Mola FF, di Sebastiano P, Andriulli A


2016; ():

Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.

Fontana A, Copetti M, Di Gangi IM, Mazza T, Tavano F, Gioffreda D, Mattivi F, Andriulli A, Vrhovsek U, Pazienza V


2016; ():

DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, Mazzoccoli G, Faulkes C, Pata I, Agodi A, Rezaee F, Minogue S, Warren A, Peterson A, Sedivy JM, Douet J, Buschbeck M, Cappello F, Mazza T, Pazienza V, Vinciguerra M


2016; :

Deregulated expression of cryptochrome genes in human colorectal cancer

Mazzoccoli G., Colangelo T., Panza A., Rubino A., De Cata A., Tiberio C., Valvano M.R., Pazienza V., Merla G., Augello B., Trombetta D., Storlazzi C.T., Macchia G., Gentile A., Tavano F., Vinciguerra M., Bisceglia G., Rosato V., Colantuoni V., sabatino L.


SIC 76° Congresso Nazionale 11-14 Dicembre 2015 Roma 2015; :

CHEST THUMP: ANCORA UN RUOLO NELLA RIANIMAZIONE CARDIOPOLMONARE

Di Stolfo G., Mastroianno S., Massaro R., Cianfrone N., Martino G., Potenza D.R., Fanelli R.

117° Congresso Nazionale della Società Italiana di Chirurgia. Milano 21-24 Ottobre 2015 2015; :

Chirurgia laparoscopica e toracoscopica di voluminosi diverticoli esofagei.

Cuttitta A., Del Naja C., Merla A., Palladino D., Scaramuzzi G.

2015; ():

Methotrexate is not Superior to Placebo in Inducing Steroid-free Remission, but Induces Steroid-free Clinical Remission in a Larger Proportion of Patients with Ulcerative Colitis.

Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W, Bouhnik Y, Brixi H, Seksik P, Malamut G, Färkkilä M, Cou


Giornale di Gerontologia 2015; :

IL PAZIENTE CRONICAMENTE CRITICO: UNA NUOVA SFIDA PER LA GERIATRIA

Greco A., Dagostino M.P., Addante F., Sancarlo D., Piepoli A., Chiarelli P., Miscio L., Fusilli S.

2015; 21(6): 1237-47

Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.

Trbojevic Akmacic I, Ventham NT, Theodoratou E, Vuckovic F, Kennedy NA, Krištic J, Nimmo ER, Kalla R, Drummond H, Štambuk J, Dunlop MG, Novokmet M, Aulchenko Y, Gornik O, Campbell H, Pucic Bakovic M, Satsangi J, Lauc G, IBD-BIOM Consortium


2015; 10(4): e0123028

Changes to serum sample tube and processing methodology does not cause Intra-Individual corrected variation in automated whole serum N-glycan profiling in health and disease.

Ventham NT, Gardner RA, Kennedy NA, Shubhakar A, Kalla R, Nimmo ER, IBD-BIOM Consortium, Fernandes DL, Satsangi J, Spencer DI


2015; 62: S235–S262

HISTONE VARIANT macroH2A1 ORCHESTRATES ESCAPE FROM HEPATOCYTE SENESCENCE DURING AGEING AND CANCER

Borghesan M., Panebianco C., Rappa F., Sedivy J.M., Buschbeck M., Cappello F., Mazza T., Pazienza V., Vinciguerra M.

2015; (): 1-8

Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy.

Moonen A, Annese V, Belmans A, Bredenoord AJ, Bruley des Varannes S, Costantini M, Dousset B, Elizalde JI, Fumagalli U, Gaudric M, Merla A, Smout AJ, Tack J, Zaninotto G, Busch OR, Boeckxstaens GE


Journal of ultrasound 2015; 18(4): 411-4

A rare case of sigmoid colon obstruction in patient with ulcerative colitis: role of transabdominal ultrasound-guided biopsy.

Terracciano F, Scalisi G, Attino V, Biscaglia G


2015; : e257

Whole exome sequencing of very early onset ulcerative colitis patients identifies new variants in candidate genes

Palmieri O., Aloi M., Prudente S., Mazza T., Stronati L., Corritore G., Latiano T., Bossa F., Andriulli A., Cucchiara S., Latiano A.

2015; ():

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy N


2015; 6(): 8442

Genetic sharing and heritability of paediatric age of onset autoimmune diseases.

Li YR, Zhao SD, Li J, Bradfield JP, Mohebnasab M, Steel L, Kobie J, Abrams DJ, Mentch FD, Glessner JT, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Li D, Maggadottir SM, Thomas KA, Qui H, Chiavacci RM, Kim CE, Wang F, Snyder J, Flatø B, Førre Ø, Dens


2015; 6(): 8019

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D, Canadian-US PBC Consortium, Italian PBC Genetics Study Group, UK-PBC Consortium, Gershwin ME, Anderson CA, Lazarid


2015; 12(3): 667-78

Functional Impact of Autophagy-Related Genes on the Homeostasis and Dynamics of Pancreatic Cancer Cell Lines.

Mazza T, Fusilli C, Saracino C, Mazzoccoli G, Tavano F, Vinciguerra M, Pazienza V


2015; 47(9): 979-86

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.

Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Daryani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahed


2015; 24(7): 1597-605

Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation.

Neri L, Conway PM, Basilisco G, Laxative Inadequate Relief Survey (LIRS) Group


2015; 21(9): 1018-27

Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.

Li YR, Li J, Zhao SD, Bradfield JP, Mentch FD, Maggadottir SM, Hou C, Abrams DJ, Chang D, Gao F, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Glessner JT, Li D, Kao C, Thomas KA, Qiu H, Chiavacci RM, Kim CE, Wang F, Snyder J, Richie MD, Flatø B, Førr


2015; ():

Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.

Rahimi M, Vinciguerra M, Daghighi M, Özcan B, Akbarkhanzadeh V, Sheedfar F, Amini M, Mazza T, Pazienza V, Motazacker MM, Mahmoudi M, De Rooij FW, Sijbrands E, Peppelenbosch MP, Rezaee F


2015; ():

Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.

D'Aronzo M, Vinciguerra M, Mazza T, Panebianco C, Saracino C, Pereira SP, Graziano P, Pazienza V


2015; ():

Hepatitis viruses exploitation of host DNA methyltransferases functions.

Pazienza V, Panebianco C, Andriulli A


2015; (): 1-14

Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.

Palmieri O, Mazzoccoli G, Bossa F, Maglietta R, Palumbo O, Ancona N, Corritore G, Latiano T, Martino G, Rubino R, Biscaglia G, Scimeca D, Carella M, Annese V, Andriulli A, Latiano A


2015; ():

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, G


2015; ():

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Ch


2015; ():

Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.

Palmieri O, Creanza TM, Bossa F, Palumbo O, Maglietta R, Ancona N, Corritore G, Latiano T, Martino G, Biscaglia G, Scimeca D, De Petris MP, Carella M, Annese V, Andriulli A, Latiano A


Minerva gastroenterologica e dietologica 2015; 61(1): 1-9

Value of real-time gastric juice analysis in upper gastrointestinal endoscopy.

Ummarino A, Tucci FA, Pezzicoli G, Di Virgilio AP, Parigino D, Tucci P, Bisceglia M, Rugge M, Tucci A, Andriulli A


2015; 372(12): 1104-13

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

Monteleone G, Neurath MF, Ardizzone S, Di Sabatino A, Fantini MC, Castiglione F, Scribano ML, Armuzzi A, Caprioli F, Sturniolo GC, Rogai F, Vecchi M, Atreya R, Bossa F, Onali S, Fichera M, Corazza GR, Biancone L, Savarino V, Pica R, Orlando A, Pallone F


2015; 47(2): 172-9

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.

Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S, International Inflammatory Bowel Disease Genetics Consortium, Australia and New Zealand IBDGC, Belgium IBD Gene


2015; (): 1-16

SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.

Tavano F, Pazienza V, Fontana A, Burbaci FP, Panebianco C, Saracino C, Lombardi L, De Bonis A, di Mola FF, di Sebastiano P, Piepoli A, Vinciguerra M, Fracavilla M, Giuliani F, Rubino R, Andriulli A, Mazzoccoli G


2015; 9(1): 52-7

HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.

Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T


2015; 5(): 8812

Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.

McKee C, Sigala B, Soeda J, Mouralidarane A, Morgan M, Mazzoccoli G, Rappa F, Cappello F, Cabibi D, Pazienza V, Selden C, Roskams T, Vinciguerra M, Oben JA


2015; 93S: S6

Severe dysphagia of spastic upper esophageal sphinter following encephalitis treated with high doses of IncobotulinumtoxinA (XEOMIN NT 201): a case report

Basciani M., Perri F., Esposito G., Intiso D.

2014; ():

Randomised controlled trial of mesalazine in IBS.

Barbara G, Cremon C, Annese V, Basilisco G, Bazzoli F, Bellini M, Benedetti A, Benini L, Bossa F, Buldrini P, Cicala M, Cuomo R, Germanà B, Molteni P, Neri M, Rodi M, Saggioro A, Scribano ML, Vecchi M, Zoli G, Corinaldesi R, Stanghellini V


2014; 60 (4): 871A

Management of hepatocellular carcinoma in elderly patients: an Italian ?in field? experience

Dionigi E., Borzio M., Rossini A., Toldi A., Francica G., Fornari F., Salmi A., Farinati F., Vicari S., Marignani M., Parisi G., Terracciano F., de Sio I., Sacco R.

2014; 60 (4): 1102A

Long-Term HDV-RNA Suppression ? HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy

Niro G.A., smedile A., Fontana R., Olivero A., Ciancio A., Pittalunga F., Coppola N., Wedemeyer H., Zachou K., Marrone A., Fasano M., Santantonio T., Lotti G., Andriulli A., Rizzetta M.

2014; ():

Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience.

Borzio M, Dionigi E, Rossini A, Toldi A, Francica G, Fornari F, Salmi A, Farinati F, Vicari S, Marignani M, Terracciano F, Ginanni B, Sacco R


116 CONGRESSO NAZIONALE DELLA SOCIETA ITALIANA DI CHIRURGIA, Roma 12-15 ottobre 2014 2014; :

Enucleazione laparoscopica di GIST a basso grado di malignit? dell'esofago sovracardiale

Cuttitta A., Merla A., Palladino D., Scaramuzzi G.

ORDINE NAZIONALE DEI BIOLOGI 2014; :

La sperimentazione Animale

Pazienza V.

2014; :

Transperineal ultrasound (TPUS) in pediatric perianal disease

Terracciano F., Scalisi G., Pastore M., D'Altilia M., Andriulli A., Sacco M., Sacco E.

XIX Congresso Nazionale della Società Scientifica FADOI 2014; 8(s2):

Un complesso caso di colite

Addante F., Dagostino M.P., D'Ambrosio L.P., Paris F., Antonacci D., Perri F., Greco A.

2014; 34(9): 1369-77

Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


2014; ():

Detection of Gastric Precancerous Conditions in Daily Clinical Practice: A Nationwide Survey.

Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, Di Giulio E, Buscarini E, Bianco MA, De Boni M, MAG-Study Group, Annibale B


2014; 42(5): 1409-13

Histone variants and lipid metabolism.

Borghesan M, Mazzoccoli G, Sheedfar F, Oben J, Pazienza V, Vinciguerra M


2014; ():

TRPA1 channel is a cardiac target of mIGF-1/SIRT1 signaling.

Pazienza V, Pomara C, Cappello F, Calogero R, Carrara M, Mazzoccoli G, Vinciguerra M


2014; ():

Prevalence of lesions detected at upper endoscopy: An Italian survey.

Zullo A, Esposito G, Ridola L, Hassan C, Lahner E, Perri F, Bianco MA, De Francesco V, Buscarini E, Di Giulio E, Annibale B, AIGO-SIED study group, AIGO-SIED study group


2014; 14(3): 227-30

Pancreatic abnormalities detected by endoscopic ultrasound (EUS) in patients without clinical signs of pancreatic disease: any difference between standard and Rosemont classification scoring?

Petrone MC, Terracciano F, Perri F, Carrara S, Cavestro GM, Mariani A, Testoni PA, Arcidiacono PG


2014; 12(1): 248

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

Tavano F, Fontana A, Pellegrini F, Burbaci F, Rappa F, Cappello F, Copetti M, Maiello E, Lombardi L, Graziano P, Vinciguerra M, di Mola F, di Sebastiano P, Andriulli A, Pazienza V


2014; 46(9): 799-815

Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated June 2014.

Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, Kapral C


2014; ():

Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study.

Bortoli A, Daperno M, Kohn A, Politi P, Marconi S, Monterubbianesi R, Castiglione F, Corbellini A, Merli M, Casella G, D'Incà R, Orlando A, Bossa F, Doldo P, Lecis P, Valpiani D, Danese S, Comberlato M, on behalf of Italian Group for the study of Inflamma


2014; ():

Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease.

Annese V, Vecchi M, on behalf of the Italian Group for the Study of IBD (IG-IBD), IG-IBD Governing Board, IG-IBD Governing Board


2014; ():

Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Rizzello F, D'Incà R, Orlando A


2014; 46(9): 994-1000

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, O


2014; 46(9): 818-25

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

Andriulli A, Nardi A, Di Marco V, Ippolito AM, Gavrila C, Aghemo A, Di Paolo D, Squadrito G, Grassi E, Calvaruso V, Valvano MR, Brancaccio G, Craxi A, Angelico M, Collaborators, Collaborators


2014; 49(5): 564-8

Low risk of colon cancer in patients with celiac disease.

Volta U, Vincentini O, Quintarelli F, Felli C, Silano M, Collaborating Centres of the Italian Registry of the Complications of Celiac Disease


2014; ():

Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia.

Gockel I, Becker J, Wouters MM, Niebisch S, Gockel HR, Hess T, Ramonet D, Zimmermann J, Vigo AG, Trynka G, de León AR, de la Serna JP, Urcelay E, Kumar V, Franke L, Westra HJ, Drescher D, Kneist W, Marquardt JU, Galle PR, Mattheisen M, Annese V, Latiano A


2014; ():

Overall acceptability and efficacy of commonly used bowel preparations for colonoscopy in Italian clinical practice. A multicentre prospective study.

Parente FR, Repici A, Crosta C, Cipolletta L, Testoni PA, Costamagna G, Andriulli A, Di Matteo G, Sassatelli R, Gallus S


2014; ():

Can Endoscopic Ultrasound Distinguish Between Mediastinal Benign Lymph Nodes and Those Involved by Sarcoidosis, Lymphoma, or Metastasis?

Jamil LH, Kashani A, Scimeca D, Ghabril M, Gross SA, Gill KR, Hasan MK, Woodward TA, Wallace MB, Raimondo M


2014; ():

Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.

Panebianco C, Saracino C, Pazienza V


2014; ():

Targeting human equilibrative nucleoside analog transporter (hENT1) expression through modified low glycemic index diet in pancreatic cancer.

Pazienza V, Del Nobile Matteo A


2014; 94(3): 437-52

An excess of risk-increasing low-frequency variants can be a signal of polygenic inheritance in complex diseases.

Chan Y, Lim ET, Sandholm N, Wang SR, McKnight AJ, Ripke S, DIAGRAM Consortium, GENIE Consortium, GIANT Consortium, IIBDGC Consortium, PGC Consortium, Daly MJ, Neale BM, Salem RM, Hirschhorn JN


2014; 60: S424-s425

Entecavir effectiveness in naive and nuc experienced patients with chronic hepatitis b and liver cirrhosis: interim analysis of the italian entas cohort study

E. Porro, A. Di Leo, A. Marzano, G. Brancaccio, S. Maimone, M. Fasano, A. Grasso, F. Bronte, S. Fagiuoli, T. Santantonio, F. Morisco, E. Petrelli, G. Svegliati Baroni, G. Labbadia, L. Badia, Niro GA, M. Vinci, A. Montineri, F. Vinelli, M. Massari, L. Noso

2014; 60: S312

Hcv genotype 1a and 1b: similarities and differences in clinical features, therapeutic outcome and predictors of response

F. Morisco, V. Di Marco, R. Granata, S. Camera, Ippolito A, M. Margaglione, G. Fattovich, A. Smedile, E. Clery, C. Ferraiuoli, M. Guarino, L. Donnarumma, Valvano MR, M. Milella, M.M. Felder, G.B. Gaeta, P. Gatti, P. Tundo, M. Barone, R. Cozzolongo, M. Ang

2014; 60: S144

Systems analysis of nafld gene expression unveils a protective role for macroh2a1.1 in hepatocyte against lipid accumulation

Mazza T, Borghesan M, Williams, Pazienza V, Vinciguerra M

2014; 60: S100

Histone variant macroh2a1 protects against 5-aza-2'-deoxycytidine induced hepatocyte senescence

Borghesan M, Mazza T, C. Fusilli, C. Faulkes, Pazienza V, Vinciguerra M

2014; 60: S456

A model to estimate a priori the probability of sustained virological response to peg-interferon and ribavirin for patients with hcv-1 infection

Andriulli A, Angelico M, Nardi, Ippolito A.M., C. Gravila, V. Calvaruso, Valvano M.R., V. Di Marco, A. Craxì.

2014; ():

Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high fat diet.

Sheedfar F, Vermeer M, Pazienza V, Villarroya J, Rappa F, Cappello F, Mazzoccoli G, Villarroya F, van der Molen H, Hofker MH, Koonen DP, Vinciguerra M


United European Gastroenterology 2014; 2(2): 138-147

Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation

Neri L., Basilisco G., Corazziari E., Stanghellini V., Bassotti G., Bellini M., Perelli I., Cuomo R. and LIRS Study Group

ViroVIP 2014; :

Peg-interferone alfa-2b vs peg-interferone alfa-2a: una vexata questio

Andriulli A., Favale R.A., Andriulli N.

2014; 20(15): 4197-4207

Circadian clock circuitry in colorectal cancer.

Mazzoccoli G, Vinciguerra M, Papa G, Piepoli A


2014; 46S: S123

Clinical Features, Therapeutic Outcome And Predictor Of Response In HCV Genotype 1A And 1B: Similarities And Differences

Morisco F., Di Marco V., Caporaso N., Granata R., Camera S., Ippolito A., Margaglione M., Fattovich G., Smedile A., Clery E., Ferraiuoli C., Cossiga V., Guarino M., Donnarumma L., Valvano M.R., Milella M., Felder M.M., Gaeta G.B., Gatti P., Tundo P., Baro

2014; 46S: S12

A model to predict success following peg-interferon and ribavirin therapy for patients with HCV-1 infection

Ippolito A.M., Andriulli A., Angelico M., Nardi A., Di Marco V., Smedile A., Calvaruso V., Valvano M.R., Milella M., Morisco F., Fattovich G., Felder M., Brancaccio G., Fasano M., Gatti P., Andriulli N., Tundo P., Barone M., Cozzolongo R., D'Andrea G., Ma

2014; 46s: s3

Management of HCC in elderly patients: an italian "in field" experience

Dionigi E., Borzio M., Rossini A., Toldi A., Francica G., Fornari F., Salmi A., Farinati F., Vicari S., Marignani M., Andriulli A., Ginanni B., Sacco R.

2014; ():

Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience.

di Mola FF, Tavano F, Rago RR, De Bonis A, Valvano MR, Andriulli A, di Sebastiano P


2014; 46S: S78

Infliximab in steroid-dependent ulcerative colitis: lack of predictive factors for response in a large multicenter series

M. Cappello, M. Mazza, G. Costantino, W. Fries, A.C. Privitera, M. Mastronardi, Bossa F., A. Rispo, F. Castiglione, A. Lauria, N. Buccianti, R. Marasco, L. Grossi, M.B. Principi, P.L. Almasio

2014; 46S: S20

Results of a screening program devoted to first degree relatives of crc patients: 3 years experience

Biscaglia G., Nardella M., Andriulli A.

2014; ():

Reply to "Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools"

Palmieri O, Valvano MR, Margaglione M, Andriulli A


2014; ():

Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


2014; 55: 94-116

Analytical metabolomics-based approaches to pancreatic cancer

Di Gangi I.M., Vrhovsek U., Pazienza V., Mattivi F.

2014; 9(3): e89505

Non-alcoholic Fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms.

Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Saraswati R, Novelli M, Fusai G, Rappa F, Saracino C, Pazienza V, Poston L, Taylor PD, Vinciguerra M, Oben JA


Inflammatory Bowel Diseaes - 9th Congress of ECCO 2014; : P452

Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program

Daperno M., Comberlato M., Bossa F., Bonanomi A.G., Lombardi G., Biancone L., Cosintino R., D'Incà R., Cassinotti A., Mangiarotti R., Papa A., Pica R., Rizzello F., Armuzzi A., Orlando A., on behalf of IG-IBD

Inflammatory Bowel Diseaes - 9th Congress of ECCO 2014; : P629

Epidemiological features and disease related concerns of a large cohort of Italian patients with active Crohn’s disease

Armuzzi A., Rigler G., Vecchi M., Baldoni M., Costa F., Fortuna M., Furfaro F., Iaquinto G., Paese P., Papi C., Rizzello F., Tornatore V., Bossa F.

Inflammatory Bowel Diseaes - 9th Congress of ECCO 2014; : P447

Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey

Cappello M., Mazza M., Costantino G., Fries W., Privitera A.C., Mastronardi M., Bossa F., Rispo A., Castiglione F., Lauria A., Buccianti N., Marasco R., Grossi L., Principi M.B.

2014; 20(10): 2624-2633

Hepatitis C virus, mitochondria and auto/mitophagy: Exploiting a host defense mechanism.

Ruggieri V, Mazzoccoli C, Pazienza V, Andriulli A, Capitanio N, Piccoli C


2014; ():

Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Author's reply.

Palmieri O, Valvano MR


2014; ():

Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.

Orlando A, Mocciaro F, Renna S, Scimeca D, Rispo A, Lia Scribano M, Testa A, Aratari A, Bossa F, Tambasco R, Angelucci E, Onali S, Cappello M, Fries W, D'Incà R, Martinato M, Castiglione F, Papi C, Annese V, Gionchetti P, Rizzello F, Vernia P, Biancone L,


2014; 75(4): 364-9

Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant.

Latiano A, Palmieri O, Bossa F, Latiano T, Corritore G, De Santo E, Martino G, Merla A, Valvano MR, Cuttitta A, Mazza T, Annese V, Andriulli A


Biochimica et Biophysica Acta 2014; (): 1-12

Peroxisome proliferator-activated receptor ?-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.

Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Mazzoccoli G, Colantuoni V, Piepoli A


2014; 9(1): e87075

Loss of connectivity in cancer co-expression networks.

Anglani R, Creanza TM, Liuzzi VC, Piepoli A, Panza A, Andriulli A, Ancona N


2014; 6(1): 1-13

SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.

Pazienza V, Borghesan M, Mazza T, Sheedfar F, Panebianco C, Williams R, Mazzoccoli G, Andriulli A, Nakanishi T, Vinciguerra M


115 CONGRESSO NAZIONALE DELLA SOCIETA ITALIANA DI CHIRURGIA, TORINO 13-16 ottobre 2013 2013; :

Voluminoso diverticolo epifrenico in acalasia esofagea. Miotomia cardiale e peridiverticolare laparoscopica. Iatoplastica e plastica sec. Dor

Cuttitta A., Tancredi A., Merla A., Palladino D., Scaramuzzi G.

HELLENIC JOURNAL OF SURGERY 2013; 85 (1): 42-48

Dor fundoplication after Helle Myotomy: Six Year of experience in a single centre

Tancredi A., De Santo E., Fontana A., Pellegrini F., Scaramuzzi R., Cuttitta A.

2013; 19(47): 8902-8909

Exploitation of host clock gene machinery by hepatitis viruses B and C.

Vinciguerra M, Mazzoccoli G, Piccoli C, Tataranni T, Andriulli A, Pazienza V


2013; 8(12): e82292

Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene

Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, Canaff L, Hendy GN, D'Agruma L, Zelante L, Carella M, Scillitani A, Guarnier


2013; : S17

Entecavir (ETV) prophylaxis in inactive HBV carriers who underwent chemotherapy for solid or haematological cancer: interim analysis of a cohort study

Di Marco V., Angelucci E., Pietrangelo A., Salerno F., Niro G.A., Daniele B., Vinci M., Villa E., on behalf of ChemEt Study

2013; : S17

Interim analysis of the Italian Master-Entas cohort study: entecavir effectiveness in field practice for chronic hepatitis B

Giuberti T., Fasano M., Brancaccio G., Santantonio T., Grasso A., Marzano A., Bronte F., Maimone S., Fagiuoli S., Caporaso N., Petrelli E., Svegliati Baroni G., Labbadia G., Verucchi G., Niro G.A., Pinzello G.B., Montineri A., Vinelli F., Massari M., Noso

2013; : S193-S194

A multicentre prospective observational study assessing acceptability and efficacy of most commonly used bowel cleansing preparations for colonoscopy in clinical practice in Italy

Parente F., Repici A., Crosta C., Cipolletta L., Testoni P.A., Costamagna G., Andriulli A., DiMatteo G., Sassatelli R., Gallus S.

XVI Congresso Nazionale SIGU 2013; : 15

MicroRNA-139-5p regulates human TIM expression in colon cancer cell lines

Panza A., Gentile A., Valvano R., Augello B., Tavano F., Merla G., Guarnieri V., Andriulli A., Mazzoccoli G., Piepoli A.

XVI Congresso Nazionale SIGU 2013; : P273

Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

Palmieri O., D'andrea G., De Girolamo G., Di Marco V., Margaglione M., Ippolito A.M., Fattovich G., Smedile A., Valvano M.R., Calvaruso V., Gioffreda D., Milella M., Morisco F., Felder M., Brancaccio G., Fasano M., Gatti P., Tundo P., Barone M., Cozzolong

2013; 45S: S80

Early post-operative endoscopic recurrence in Crohn’s disease: data from a large prospective italian multicenter cohort (an IG-IBD study)

A. Orlando, F. Mocciaro, Scimeca D., A. Rispo, Scribano M.L., Testa A., Aratari A., Bossa F., Tambasco R., Angelucci E., Onali S., Cappello M., Fries W., D’Incà R., Martinato M., Castiglione F., Papi C., Annese V., Gionchetti P., Rizzello F., Vernia P., B

2013; : S-471

Genetic Risk Profiling of Complicated Disease Course in Crohn's Disease Patients

Latiano A., Palmieri O., Buccianti N., Scimeca D., Biscaglia G., Valvano M.R., D'Incà R., Annese V., Andriulli A.

2013; 58: S311

Entecavir effectiveness in daily clinical practice, interim analysis of the italian master-entas cohort study of patients with chronic Hepatitis B

Giuberti T., Fasano M., Brancaccio G., Santantonio T., Grasso A., Marzano A., Bronte F., Maimone S., Fagiuoli S., Caporaso N., Petrelli E., Svegliati Baroni G., Labbadia G., Verucchi G., Niro G.A., Pinzello G.B., Montineri A., Vinelli F., Massari M., Noso

2013; 58: S301

Efficacy and safety of entecavir (ETV) prophylaxis in inactive HBV carriers who underwent chemotherapy for solid or haematological cancer: interim analysis of a cohort study

Di Marco V., Angelucci E., Pietrangelo A., Salerno F., Niro G.A., Daniele B., Vinci M., Villa E., ChemEt Study Group of the Associazione Italiana per lo Studio del Fegato (AISF)

2013; : S-436 (Su1237)

A Retrospective Multicenter Survey on Infliximab Efficacy and Safety in Moderate-to-Severe and Steroid-Dependent Ulcerative Colitis

Cappello M., Mazza M., Costantino G., Fries W., Privitera A.C., Mastronardi M., Buccianti N., Castiglione F., R., Lauria A., Marasco R., Almasio P.L., Bossa F.

2013; : S205

Infliximab in moderate-to-severe ulcerative colitis: efficacy and safety in a “real life” retrospective multicenter study from southern Italy

Cappello M., Mazza M., Costantino G., Fries W., Privitera A.C., Mastronardi M., Bossa F. , Castiglione F., Rispo A., Lauria A., Buccianti N., Marasco R., Almasio P.L.

2013; 45: S56

Hepatitis delta virus (HDV) induces specific DNA methylation events towards malignancy in hepatoma cells

Benegiamo G., Vinciguerra M., Guarnieri V., Niro G.A., Andriulli A., Pazienza V.

AISD - 36° Congresso Nazionale 2013; : 55

Safety and efficacy of effentora to treat acute moderate oncological pain in a cirrhotic patient without previous strong opioid therapy

Latina P., Andriulli A., Niro A., Conoscitore P., Ippolito A., Nardella M., Iacobellis A.

2013; 88(3): 696-705

Chemokine receptor CXCR4: Role in gastrointestinal cancer.

Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E


2013; 19(44): 7930-7946

Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas.

Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M, the Exocrine Pancreatic Insufficiency collaborative (EPIc) Group


2013; 108(7): 1178-80

BAG3 is a novel serum biomarker for pancreatic adenocarcinomas.

Falco A, Rosati A, Festa M, Basile A, De Marco M, d'Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF, di Sebastiano P, Berloco PB, Nudo F, Caraglia M, Febbraro A, Barcaroli D, Scarpa A, Pezzilli R, De Laurenzi V, Turco MC


2013; 45(12): 1003-10

Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.

Tavano F, Palmieri O, di Mola FF, Latiano A, Burbaci FP, Valvano MR, Corritore G, Augello B, Merla G, Annese V, Andriulli A, di Sebastiano P


Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P321

The TT/-G frameshift variant of the novel IFNL4 gene not improves HCV1 clearance prediction

Palmieri O., D'andrea G. , Ippolito A.M., De Girolamo G. , Margaglione M., Latiano A., Valvano M.R., Gioffreda D., Fasano M., Milella M., Morisco F., Montalto G., Gatti P., Tundo P., Barone M., Cozzolongo R., Santantonio T., Andriulli A.

Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P279

Raro caso di sincrona insorgenza di carcinoma delle paratiroidi e delle vie biliari extraepatiche (coledoco): analisi di CNV rivela nuovi possibili geni coinvolti nella tumorigenesi delle due diverse patologie

Palumbo O., Salcuni A.S., Clemente C., Caruso N., Battista C., Di Candia L. , Bisceglia M., Maiello E., Scillitani A., Guarnieri V.

2013; 36(8): 600-5

Variations of serum levels of adiponectin and resistin in chronic viral hepatitis.

Durazzo M, Belci P, Niro G, Collo A, Grisoglio E, Ambrogio V, Spandre M, Fontana R, Gambino R, Cassader M, Bo S


2013; ():

Genetic variation in the lymphotoxin-? (LTA)/tumour necrosis factor-? (TNF?) locus as a risk factor for idiopathic achalasia.

Wouters MM, Lambrechts D, Becker J, Cleynen I, Tack J, Vigo AG, Ruiz de León A, Urcelay E, Pérez de la Serna J, Rohof W, Annese V, Latiano A, Palmieri O, Mattheisen M, Mueller M, Lang H, Fumagalli U, Laghi L, Zaninotto G, Cuomo R, Sarnelli G, Nöthen MM, V


Journal of the Pancreas 2013; 14(6): 618-25

Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: a meta-analytical evaluation of prospective studies.

Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Andriulli N, Corrao S, Koch M


2013; 6(): 37

Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment.

Mazzoccoli G, Tomanin R, Mazza T, D Avanzo F, Salvalaio M, Rigon L, Zanetti A, Pazienza V, Francavilla M, Giuliani F, Vinciguerra M, Scarpa M


2013; 108(7): 1112-22

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.

Bruno S, Saibeni S, Bagnardi V, Vandelli C, De Luca M, Felder M, Fracanzani AL, Prisco C, Vitaliani G, Simone L, Gaeta GB, Stanzione M, Persico M, Furlan C, Stroffolini T, Salerno F, Maisonneuve P, Almasio PL, AISF (Italian Association for the Study of th


2013; 60(1): 16-21

Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin.

Andriulli A, Marco VD, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate M


2013; 8(9): e72928

Sympathetic Nervous System Catecholamines and Neuropeptide Y Neurotransmitters Are Upregulated in Human NAFLD and Modulate the Fibrogenic Function of Hepatic Stellate Cells.

Sigala B, McKee C, Soeda J, Pazienza V, Morgan M, Lin CI, Selden C, Vander Borght S, Mazzoccoli G, Roskams T, Vinciguerra M, Oben JA


2013; ():

The circadian clock and the hypoxic response pathway in kidney cancer.

Mazzoccoli G, De Cata A, Piepoli A, Vinciguerra M


Minerva Gastroenterologica e dietologica 2013; 59(1): 97-105

Perendoscopic real-time assessment of pH improves detection of gastric preneoplastic conditions.

Pezzicoli G, Tucci FA, Ummarino A, Tucci P, Di Virgilio AP, Bisceglia M, Rugge M, Tucci A, Andriulli A


2013; 20(7): 502-9

Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


2013; 114(1): 64-8

Affinity analysis of differentially expressed genes in hepatocytes expressing HCV core genotype 1b or 3a.

Mazza T, Castellana S, Andriulli A, Auffray C, Vinciguerra M, Pazienza V


2013; 45(9): 738-43

Adalimumab in active ulcerative colitis: A "real-life" observational study.

Italian Group for the Study of Inflammatory Bowel Disease


2013; 19(9): 1872-9

Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis: A Randomized, Double-blind Sham-controlled Study.

Bossa F, Annese V, Valvano MR, Latiano A, Martino G, Rossi L, Magnani M, Palmieri O, Serafini S, Damonte G, De Santo E, Andriulli A


2013; 145(2): 339-47

Association Between Variants of PRDM1 and NDP52 and Crohn's Disease, Based on Exome Sequencing and Functional Studies.

Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Häsler R, Boehm BO, Goodall J, Berzuini CR, Lee J, An


2013; 587(9): 1424-8

Hepatitis delta virus induces specific DNA methylation processes in Huh-7 liver cancer cells.

Benegiamo G, Vinciguerra M, Guarnieri V, Niro GA, Andriulli A, Pazienza V


2013; 51(9): 1707-17

Advance in molecular diagnostic tools for hepatitis B virus detection.

Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A


2013; 45(6): 670-5

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Sriv


2013; 8(4): e62144

Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease.

Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G, Settesoldi A, Valvano MR, D'Incà R, Stronati L, Annese V, Andriulli A


2013; 8(4): e60527

Mutual Antagonism between Circadian Protein Period 2 and Hepatitis C Virus Replication in Hepatocytes.

Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V


2013; 1833(8): 1853-65

Interplay between SOX9, ?-catenin and PPAR? activation in colorectal cancer.

Panza A, Pazienza V, Ripoli M, Benegiamo G, Gentile A, Valvano MR, Augello B, Merla G, Prattichizzo C, Tavano F, Ranieri E, Sebastiano PD, Vinciguerra M, Andriulli A, Mazzoccoli G, Piepoli A


2013; 27(1): 9-22

Transcriptional regulators, the circadian clock and the immune system.

Vinciguerra M, Borghesan M, Pazienza V, Piepoli A, Palmieri O, Tarquini R, Tevy MF, De Cata A, Mazzoccoli G


2013; 2013 - suppl 1: s 278 - p667

Dissecting the role of unfolded protein response pathway in inflammatory bowel disease: in silico mRNA-miRNA co-expression analysis

Palmieri O, Bossa F, Creanza MT, Latiano T, Corritore G, Scimeca D, Biscaglia G, Liuzzi VC, Anglani R, Carella M, Annese V, Andriulli A, Latiano A

2013; 45(7): 606-11

Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: Results of an Italian multicenter study.

Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Berta


2013; 62(2): 290-8

Randomised study comparing 48 and 96 weeks peginterferon ?-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M, PegBeLiver Study Group


2013; 14(3): 179-86

Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

Kar SP, Seldin MF, Chen W, Lu E, Hirschfield GM, Invernizzi P, Heathcote J, Cusi D, the Italian PBC Genetics Study Group, Almasio PL, Alvaro D, Andreone P, Andriulli A, Barlassina C, Benedetti A, Bernuzzi F, Bianchi I, Bragazzi M, Brunetto M, Bruno S, Cal


2013; 9(2): 283-94

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.

Borzio M, Fornari F, De Sio I, Andriulli A, Terracciano F, Parisi G, Francica G, Salvagnini M, Marignani M, Salmi A, Farinati F, Carella A, Pedicino C, Dionigi E, Fanigliulo L, Cazzaniga M, Ginanni B, Sacco R


2013; ():

MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.

Aretz S, Tricarico R, Papi L, Spier I, Pin E, Horpaopan S, Cordisco EL, Pedroni M, Stienen D, Gentile A, Panza A, Piepoli A, de Leon MP, Friedl W, Viel A, Genuardi M


2013; 8(1): e54458

Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma.

Rappa F, Greco A, Podrini C, Cappello F, Foti M, Bourgoin L, Peyrou M, Marino A, Scibetta N, Williams R, Mazzoccoli G, Federici M, Pazienza V, Vinciguerra M


2012; 2012, 39: 600-606

Reply: Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU)

Novelli A, Grati FR, Ballarati L, Bernardini L, Bizzoco D, Camurri L, Casalone R, Cardarelli L, Cavalli P, Ciccone R, Clementi M,Dalprà L, Gentile M, Gelli G, Grammatico P, Malacarne M, Nardone AM, Pecile V, Simoni G, Zuffardi O, Giardino D

2012; 2012(): 918079

PPARs and Gastrointestinal Cancer.

Pazienza V


XIV National Congress of Medical Oncology 2012; 27/29 ottobre 2012: S41 - B42

Chemokine receptor CXCR4: what is its role in gastrointestinal cancer?

Lombardi L, Tavano F, Piepoli A, Di Maggio G, Latiano TP, Nanni L, Andriulli A, Di Sebastiano P, Maiello E

2012; 12(): 608

Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.

Maglietta R, Liuzzi VC, Cattaneo E, Laczko E, Piepoli A, Panza A, Carella M, Palumbo O, Staiano T, Buffoli F, Andriulli A, Marra G, Ancona N


2012; ():

Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium.

Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Fave GD, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas


2012; ():

Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


2012; 41(8): 1355-6

Preoperative Biliary Drainage and Surgical Outcome After Pancreaticoduodenectomy

Di Mola FF, Tavano F, De Bonis A, Grottola T, Tardio M, Valvano MR, Andriulli A, Di Sebastiano P

PANCREATOLOGY - 44th European Pancreatic Club (EPC) Meeting 2012; : P99

Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy

di Mola FF, Tavano F, Rago RR, Tardio M, Valvano MR, di Sebastiano P

PANCREATOLOGY - 44th European Pancreatic Club (EPC) Meeting 2012; : P81

Neoadjuvant chemo-radiotherapy for Patients with Borderline Resectable Pancreatic Cancer: A Meta-analytical evaluation of Prospective Studies

Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Corrao S, Koch M

JOP. J Pancreas - AISP - 36th National Congress 2012; 13(5 Suppl): 644

Changes in MicroRNAs Expression and Clinical Associations in Patients with Neuroendocrine Pancreatic Tumors

Tavano F, di Mola F, Burbaci F, Lombardi L, Copetti M, Piepoli A, Andriulli A, Maiello E, di Sebastiano P

XIV Congresso Nazionale AIOM 2012; :

Chemokine receptor cxcr4: what is its role in gastrointestinal cancer?

Lombardi L, Tavano F, Piepoli A, Di Maggio G, Latiano TP, Nanni L, Andriulli A,di Sebastiano P, Maiello E.

2012; 367(16): 1519-28

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG, CERTIFI Study Group


2012; :

Epidemiology and diagnosis of hepatitis D virus

Niro GA, Fontana R, Ippolito AM, Andriulli A

2012; 29(10): 1300-11

Differential Patterns in the Periodicity and Dynamics of Clock Gene Expression in Mouse Liver and Stomach.

Mazzoccoli G, Francavilla M, Pazienza V, Benegiamo G, Piepoli A, Vinciguerra M, Giuliani F, Yamamoto T, Takumi T


2012; 491(7422): 119-24

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakr


2012; ():

Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NALFD).

Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M


2012; 53(8): 885-92

Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study.

Sperandeo M, Varriale A, Sperandeo G, Polverino E, Feragalli B, Piattelli ML, Maggi MM, Palmieri VO, Terracciano F, De Sio I, Villella M, Copetti M, Pellegrini F, Vendemiale G, Cipriani C


2012; 31(4): 731-40

TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia.

Seripa D, Bizzarro A, Pilotto A, Palmieri O, Panza F, D'Onofrio G, Gravina C, Archetti S, Daniele A, Borroni B, Padovani A, Masullo C


2012; 237(10): 1123-8

The expression of leucine-rich repeat gene family members in colorectal cancer.

Piepoli A, Palmieri O, Maglietta R, Panza A, Cattaneo E, Latiano A, Laczko E, Gentile A, Carella M, Mazzoccoli G, Ancona N, Marra G, Andriulli A


2012; 2012(): 560846

PPARs Signaling and Cancer in the Gastrointestinal System.

Pazienza V, Vinciguerra M, Mazzoccoli G


2012; 36(8): 717-24

Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations.

Repici A, Cestari R, Annese V, Biscaglia G, Vitetta E, Minelli L, Trallori G, Orselli S, Andriulli A, Hassan C


2012; 21(23): 5209-5221

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Mason AL, Myers RP, Milkiewicz P, Od


2012; 2012(): 461784

Correlations among PPAR?, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer.

Pazienza V, Tavano F, Benegiamo G, Vinciguerra M, Burbaci FP, Copetti M, di Mola FF, Andriulli A, di Sebastiano P


2012; 32(3): 228-36

Clinical features of hepatitis d.

Farci P, Niro GA


2012; 41(8): 1280-4

Changes in miR-143 and miR-21 Expression and Clinicopathological Correlations in Pancreatic Cancers.

Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E, Andriulli A, di Sebastiano P


2012; 2012(): 890875

Time-Qualified Patterns of Variation of PPAR?, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.

Pazienza V, Tavano F, Francavilla M, Fontana A, Pellegrini F, Benegiamo G, Corbo V, di Mola FF, Di Sebastiano P, Andriulli A, Mazzoccoli G


2012; 29(8): 994-1003

Association Study of a Polymorphism in Clock Gene PERIOD3 and Risk of Inflammatory Bowel Disease.

Mazzoccoli G, Palmieri O, Corritore G, Latiano T, Bossa F, Scimeca D, Biscaglia G, Valvano MR, D'Incà R, Cucchiara S, Stronati L, Annese V, Andriulli A, Latiano A


2012; 44(11): 952-6

A unifying working hypothesis for Juvenile polyposis syndrome and Ménétrier's disease: Specific localization or concomitant occurrence of a separate entity?

Piepoli A, Mazzoccoli G, Panza A, Tirino V, Biscaglia G, Gentile A, Valvano MR, Clemente C, Desiderio V, Papaccio G, Bisceglia M, Andriulli A


2012; 107(3): 548-52

CASR gene activating mutations in two families with autosomal dominant hypocalcemia.

Guarnieri V, Valentina D'Elia A, Baorda F, Pazienza V, Benegiamo G, Stanziale P, Copetti M, Battista C, Grimaldi F, Damante G, Pellegrini F, D'Agruma L, Zelante L, Carella M, Scillitani A


2012; ():

Anti-correlation between longevity gene SirT1 and Notch signaling in ascending aorta biopsies from patients with bicuspid aortic valve disease.

Sciacca S, Pilato M, Mazzoccoli G, Pazienza V, Vinciguerra M


2012; 13(6): 461-468

Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.

Invernizzi P, Ransom M, Raychaudhuri S, Kosoy R, Lleo A, Shigeta R, Franke A, Bossa F, Amos CI, Gregersen PK, Siminovitch KA, Cusi D, de Bakker PI, Podda M, Gershwin ME, Seldin MF, The Italian PBC Genetics Study Group


2012; 367(8): 716-24

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group


2012; 26(2): 265-76

REV-ERBalpha and the clock gene machinery in mouse peripheral tissues: a possible role as a synchronizing hinge.

Mazzoccoli G, Cai Y, Liu S, Francavilla M, Giuliani F, Piepoli A, Pazienza V, Vinciguerra M, Yamamoto T, Takumi T


2012; 26(2): 303-11

Clock gene expression in mouse kidney and testis: analysis of periodical and dynamical patterns.

Mazzoccoli G, Francavilla M, Giuliani F, Aucella F, Vinciguerra M, Pazienza V, Piepoli A, Benegiamo G, Liu S, Cai Y


2012; 18th Congress of Digestive Diseases - 44s P.05.13: s115-s116

Infliximab versus adalimumab in crohn's disease patients in daily clinical practice. A prospective single center experience_

Bossa F, Annese V, Scimeca D, Biscaglia G, Colombo E, Martino G, De Santo E, Andriulli A

2012; 18th Congress of Digestive Diseases 44s: s68-s69

Adalimumab in active ulcerative colitis: a "real life" observation study_

Armuzzi A, Biancone L, Daperno M, Coli A, Annese V, Ardizzone S, Balestrieri P, Bossa F, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onalli S, Orlando A,

2012; 142, issue 5, s1, 868: s149-s150

Immunochip -Based Analysis of a Large IBD Case-Control Cohort Identities 50 Novel Loci, Refining Definitions of Disease Pathways

Cho JH, IIBDGC, Latiano A, Bossa F, Palmieri O

2012; 142,issue 5, s1, sa1887: s350-s351

Adalimumab in Activa Ulcerative Colitis: A"Real-Life" Observational Study

Armuzzi A, Biancone L, Daperno M, Coli A, Annese V, Ardizzone S, Balestrieri P, Bossa F, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Papi C, Pap

2012; 142, issue 5, s1: s536

Interobserver Agreement in IBD Endoscopic Scoring: Preliminary Results of an Ongoing IG-IBD study

Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papi C, Pica R, Rizzello F, D'Incà R

2012; 56(6): 1254-8

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years.

Fasano M, Lampertico P, Marzano A, Di Marco V, Anna Niro G, Brancaccio G, Marengo A, Scotto G, Rossana Brunetto M, Battista Gaeta G, Rizzetto M, Angarano G, Santantonio T


2012; 57(6): 1598-603

DNA methyltransferases 1 and 3b expression in huh-7 cells expressing HCV core protein of different genotypes.

Benegiamo G, Vinciguerra M, Mazzoccoli G, Piepoli A, Andriulli A, Pazienza V


2012; 44s-oc.12.3: s81

Early Post-operative endoscopic recurrence in crohn's disease in a large prospective italian multicente cohort

Orlando A, Mocciaro F, Scimeca D, Rispo A, Scribano ML, Testa A, Aratari A, Bossa F, Tambasco R, Angelucci E, Onali S, Cappello M, Fries W, D'Incà R, Martinato M, Castiglione F, Papi C, Annese V, Gionchetti P, Rizzello F, Vernia P, Biancone L, Perricone G

2012; 44s-oc.12.2: s81

Patients' and physicians' views on quality of care in inflammatory bowel disease: initial results from an ongoing prospective IG-IBD study

Bortoli A, Daperno M, Kohn A, Comberlato M, Politi P, Castiglione F, Valpiani D, D'Incà R, Marconi S, Merli M, Boni F, Casella G, Orlando A, Bossa F, Doldo P

2012; 44-p.12.6: s162

Adherence to screening colonoscopy in a high risk population, first-degree relatives of patients with colorectal cancer

Biscaglia G, Nardella M, Andriulli A

2012; 6-p230: s101

Adalimumab in active ulcerative colitis: A "real-life" observational study

Armuzzi A, Biancone L, Daperno M, Coli A, Avvese V, Ardizzone S, Balestrieri P, Bossa F, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Ona

2012; 6-p181: s81-s82

Patients’ and physicians’ views on quality of care in inflammatory bowel disease: Initial results from an ongoing prospective IG-IBD study

Bortoli A, Kohn A, Daperno M, D'Incà R, Orlando A, Bossa F, Doldo P, Comberlato M, Politi P, Valpiani D

2012; 6-p291: s126

Infliximab versus adalimumab in Crohn's disease patients in daily clinical practise. A prospective single center experience

Bossa F, Annese V, Scimeca D, Biscaglia G, Colombo E, Martino G, De Santo E, Andriulli A

2012; 6-p289: s125

Concordance in IBD endoscopic scoring requires expertise and training: Preliminary results of an ongoin IG-IBD study

Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi A, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Orlando A, Papa A, Pica R, Rizzello F, D'Incà R

2012; 6-p448: s187

Polymorphism in IL-33, IL1RL1 genes and risk of inflammatory bowel disease

Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro T, Bossa F, Merla G, Augello B, Valvano MR, D'Incà R, Cucchiara S, Annese V, Andriulli A,

2012; 44s: s80

Interobserver agreement in IBD scores requires expertise and education: preliminary results from an ongoing IG-IBD study

Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi A, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Orlando A, Papa A, Pica R, Rizzello F, Incà RD, Dincà R, IG-IBD

2012; 6(5): 563-70

Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels.

Tavano F, di Mola FF, Latiano A, Palmieri O, Bossa F, Valvano MR, Latiano T, Annese V, Andriulli A, di Sebastiano P


2012; 56: s174

Hepatitis Delta Virus upregulates DNMT3B through STAT3 activation in HUH-7 cells

Benegiamo G, Vinciguerra M, Mazzoccoli G, Guarnieri V, Niro G, Andriulli A, Pazienza V

2012; 56: s426

PEG-interferon and ribavirin in HCV-related cirrhotic patients with profound thrombocytopenia

Andriulli A, Iacobellis A, Iannacone C, Angarano G, Adinolfi A, Persico M, Mangia A, Fattovich G, Capra F, Rizzetto M, Golotta C

2012; 56: s427

A substantial proportion of naive HCV-1 infected patients with chronic infection may benefit from current standard therapy with PEG-interferon and ribavirin

Andriulli A, Valvano MR, Spirito F, Ippolito A, Iacobellis A, Bossa F, Terracciano F, Niro G

2012; 56: s500

Histone variant macroH2A1 knock-out worsens high fat diet-induced systemic insulin resistance, glucose intollerance and hepatic steatosis in mice

Koonen D, Pazienza V, Pehrson JR, Hofker M, Ladurner AG, Greco A, Podrini C, Vinciguerra M

2012; 56: S262

Hemorrhagic complications following invasive procedures in cirrhotic patients with normal or abnormal coagulopathy. A prospective study

Napolitano G, Valvano MR, Caruso N, Merla A, Lauriola W, Ippolito A, Siena D, Niro G, Florio F, Andriulli A

2012; 13 Suppl 4(): S21

BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments.

Consiglio A, Carella M, De Caro G, Delle Foglie G, Giovannelli C, Grillo G, Ianigro M, Licciulli F, Palumbo O, Piepoli A, Ranieri E, Liuni S


2012; 90(4): 636-47

Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci.

Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, Debrus S, Raelson JV, Tejasvi T, Belouchi M, West SL, Barker JN, Kõks S, Kingo K, Balschun T, Palmieri O, Annese V, Gieger C, Wichmann HE, Kabesch M, Trembath RC, Mathew CG, Abecasis GR,


2012; 66(3): 175-9

Altered expression of the clock gene machinery in kidney cancer patients.

Mazzoccoli G, Piepoli A, Carella M, Panza A, Pazienza V, Benegiamo G, Palumbo O, Ranieri E


2012; 29(3): 227-51

Clock genes and clock-controlled genes in the regulation of metabolic rhythms.

Mazzoccoli G, Pazienza V, Vinciguerra M


2012; 7(3): e33663

Mirna expression profiles identify drivers in colorectal and pancreatic cancers.

Piepoli A, Tavano F, Copetti M, Mazza T, Palumbo O, Panza A, di Mola FF, Pazienza V, Mazzoccoli G, Biscaglia G, Gentile A, Mastrodonato N, Carella M, Pellegrini F, di Sebastiano P, Andriulli A


2012; 107(3): 490

EUS-Guided FNA of Solid Pancreatic Masses With or Without On-Site Cytological Evaluation: More Sample Adequacy With Less Needle Passes?

Perri F


2012; 56(4): 782-7

(13)C-Aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C.

Rocco A, de Nucci G, Valente G, Compare D, D'Arienzo A, Cimino L, Perri F, Nardone G


Current infectious disease reports 2012; 14(1): 9-14

Current concept in the pathophysiology of hepatitis delta infection.

Niro GA, Smedile A


The Eurasian Journal of Medicine 2011; 43(3): 133-40

Fundoplication after heller myotomy: a retrospective comparison between nissen and dor.

Cuttitta A, Tancredi A, Andriulli A, De Santo E, Fontana A, Pellegrini F, Scaramuzzi R, Scaramuzzi G


THE EURASIAN JOURNAL OF MEDICINE 2011; :

Fundoplication After Heller Myotomy: A Retrospective

Cuttitta A., Tancredi A., Andriulli A., De Santo E., Fontana A., Pellegrini F., Scaramuzzi R., Scaramuzzi G.

2011; 43 Suppl 2 UCTN(): E419

Closure of a gastrocutaneous fistula by a tulip-bundle technique.

Perri F, Gentile M, Scimeca D, Terracciano F, Merla A, Spirito F, Andriulli A


2011; 43 Suppl 2 UCTN(): E408-9

Endoscopic removal of gallstone impacted in the rectum.

Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Andriulli A


2011; ():

ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A


2011; ():

Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms.

Maltese P, Palma L, Sfara C, de Rocco P, Latiano A, Palmieri O, Corritore G, Annese V, Magnani M


2011; 6(7): e22688

Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.

Latiano A, Palmieri O, Latiano T, Corritore G, Bossa F, Martino G, Biscaglia G, Scimeca D, Valvano MR, Pastore M, Marseglia A, D'Incà R, Andriulli A, Annese V


2011; :

SIRT1 and the Clock Gene Machinery in Colorectal Cancer

Pazienza V, Piepoli A, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Mazzoccoli M


2011; 18(3): 235-52

Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review.

Bisceglia M, Perri F, Tucci A, Tardio M, Panniello G, Vita G, Pasquinelli G


2011; 396(3): 345-51

A modified fast-track program for pancreatic surgery: a prospective single-center experience.

di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, di Mola FF


XIV Congresso Nazionale della Società  Italiana di Genetica Umana 2011; :

Beat: bioinformatics exon array tool to store, analyze and visualize affymetrix gene chip human exon array data from disease experiments

A. Consiglio, M. Carella, G. De Caro, G. Delle Foglie, C. Giovannelli, G. Grillo, M. Ianigro, F. Licciulli, O. Palumbo, A. Piepoli, E. Ranieri, S. Liuni

XIV Congresso Nazionale della Società  Italiana di Genetica Umana 2011; : 486

MicroRNA-145 regulates human SOX9 expression in colon cancer cell lines

A. Piepoli, A. Panza, V. Pazienza, A. Gentile, G. Mazzoccoli, G. Benegiamo, G. Biscaglia, F. Tavano, N. Mastrodonato, P. Di Sebastiano, Andriulli A.

2011; ():

mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart.

Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, Giuliani A, Rosenthal N


2011; :

Abstract E25 - XIII Congresso Nazionale di Oncologia Medica, Bologna 2011

Piepoli A et al.

2011; 43(11): 1066-73

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, Boucher G, Ripke S, Ellinghaus D, Burtt N, Fennell T, Kirby A, Latiano A, Goyette P, Green T, Halfvarson J, Haritunians T, Korn JM, Kuruvilla F, Lagacé C, Neale B, Lo KS, Schumm P, Törkvist


2011; 25(2): 249-57

Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans.

Mazzoccoli G, Carughi S, Sperandeo M, Pazienza V, Giuliani F, Tarquini R


2011; ():

Alteration of Hypothalamic-Pituitary-Thyroid Axis Function in Non-Small-Cell Lung Cancer Patients.

Mazzoccoli G, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Sothern RB


2011; 28(10): 841-51

Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients.

Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, Piepoli A


2011; 24(4):

Time-related dynamics of variation in core clock gene expression levels in tissues relevant to the immune system

G. Mazzoccoli, R.B. Sothern, A. Greco, V. Pazienza, M. Vinciguerra, S. Liu And Y. Cai


Biomedicine & Aging Pathology 2011; 1: 129-137

Chronobiologic study of neuro-endocrine axis hormone sequence signalling in healthy men

Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Dagostino MP, Giuliani F

2011; ():

Circadian Aspects of Growth Hormone-Insulin-Like Growth Factor Axis Function in Patients With Lung Cancer.

Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Tarquini R


2011; 25(3): 405-16

Alteration of circadian rhythmicity of CD3+CD4+ lymphocyte subpopulation in healthy aging.

Mazzoccoli G, Carughi S, Sperandeo M, Pazienza V, Giuliani F, Greco A


2011; 54(4): 605A

Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

Niro GA et al.

2011; 54(4): 1038A

Hepatitis Delta Virus Exerts An Epigenetic Control Over Hepatitis B Virus Transcription/Replication Activity

Raffa et al.

2011; 54(4): 1077A

Kinetics Of Hdv-Rna And Hepatitis B Surface Antigen In Chronic Delta Hepatitis Under Pegylated Interferon And/Or Nucleoside Analogs Therapy

Olivero et al.

2011; 54(4): 403A-404A

Treatment Of Patients With Acute Hcv Monoinfection May Be Delayed After Week 24 According With Il28b Single Nucleotide Polymorphisms (Snp) Results And Independently Of Hepatitis C Virus (Hcv) Genotype

Mangia A. et al.

2011; 54(4): 611A

Effectiveness Of Entecavir In Field Practice: Interim Analysis Of The Italian Master-Entas Cohort Study Of Patients With Chronic Hepatitis B

Giuberti et al.

2011; ():

Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies.

Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD


2011; 43(s1): A333

Low volume bowel preparation for colonoscopy: a comparison between peg-cs and bisacodyl vs peg-asc

A. Repici, R. Cestari, V. Annese, G. Biscaglia, S. Morini, A. San Romerio, G. Brunetti, E. Vitetta, L. Minelli, G. Trallori, C. Hassan, A. Andriulli

2011; :

MicroRNA and Colon-Cancer: The Circadian Clock Connection

Ada Piepoli, Anna Panza, Gianluigi Mazzoccoli, Massimiliano Copetti, Orazio Palumbo, Massimo Carella, Annamaria Gentile, Valerio Pazienza, Francesca Tavano, Nicola Mastrodonato, Giuseppe Biscaglia, Fabio Pellegrini, Pierluigi Di Sebastiano, Angelo Andriul

2011; AGA Abstracts: S-272

Dissection of the Crohn's Disease Transcriptome of 71 Loci Using Genome-Wide Microarrays

Orazio Palmieri, Anna Latiano, Rosalia Maglietta, Orazio Palumbo, Giuseppe Corritore, Tiziana Latiano, Giuseppina Martino, Massimo Carella, Nicola Ancona, Fabrizio Bossa, Angelo Andriulli, Vito Annese

2011; : S161

Whole-transcript human gene expression pathway analysis in Crohn's disease

O. Palmieri, A. Latiano, R. Maglietta, B. Fabrizio, D. Scimeca, G. Biscaglia, O. Palumbo, M. Carella, N. Ancona, A. Andriulli, V. Annese

2011; 54: S209-S361

Efficacy and tolerance of tenofovir in suboptimal responders to adv or adv/lam treatment: 96 weeks results of the optib italian multicenter prospective open label stud

M. Levrero, L. Cimino, P. Lampertico, M. Vigano’, G.B. Gaeta, G. Brancaccio, E. Sagnelli, V. Messina, G. Raimondo, A. Marzano, F. Stefano, G. Niro, T. Santantonio, M. Puoti, V. Di Marco, G. Mazzella, G. Di Costanzo, M. Angelico, B. Testoni, C. Sava’,

2011; AISF Annual Meeting 43S: S105

OptiB Italian multicenter prospective study on tenofovir in suboptimal responders to ADV or ADV/LAM treatment: 96 weeks results on efficacy and tolerance

M. Levrero, L. Cimino, P. Lampertico, M. Vigano, G.B. Gaeta, G. Brancaccio, E. Sagnelli, V. Messina, G. Raimondo, A. Marzano, S. Fagiuoli, G. Niro, T. Santantonio, M. Puoti, V. Di Marco, G. Mazzella, G.G. Di Costanzo, M. Angelico, S. Pierconti, C. Sava’

2011; 9(9): 747-59

Impact of HCV genetic differences on pathobiology of disease.

Ripoli M, Pazienza V


2011; 129(3): 536-45

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.

Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P


2011; ():

Antiphase signalling in the neuroendocrine-immune system in healthy humans.

Mazzoccoli G, Muscarella LA, Fazio VM, Piepoli A, Pazienza V, Dagostino MP, Giuliani F, Polyakova VO, Kvetnoy I


2011; ():

Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein.

Ripoli M, Barbano R, Balsamo T, Piccoli C, Brunetti V, Coco M, Mazzoccoli G, Vinciguerra M, Pazienza V


2011; ():

Ophthalmological complications in hepatitis C virus infection: Side effect of interferon therapy or a direct role of HCV?

Pazienza V


2011; ():

Genetics and Ulcerative Colitis: What are the Clinical Implications?

Latiano A, Annese V


2011; 18(7): e206-11

Unawareness of HBV infection among inpatients in a Southern Italian hospital.

Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


2011; ():

Mucin Expression Pattern in Pancreatic Diseases: Findings From EUS-Guided Fine-Needle Aspiration Biopsies.

Carrara S, Cangi MG, Arcidiacono PG, Perri F, Petrone MC, Mezzi G, Boemo C, Talarico A, Cin ED, Grassini G, Doglioni C, Testoni PA


Biomedicine & Aging Pathology 2011; 1: 39-45

Age-related changes of GH-IGF1 axis function

Mazzoccoli G, Inglese M, Dagostinoa MP, Piepoli A, Muscarella LA, Pazienza V, Tarquini R, Giuliani F

2011; 364(19): 1807-16

Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia.

Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, Elizalde JI, Fumagalli U, Gaudric M, Rohof WO, Smout AJ, Tack J, Zwinderman AH, Zaninotto G, Busch OR, European Achalasia Trial Investigators


2011; ():

Discovering genetic variants in Crohn's disease by exploring genomic regions enriched of weak association signals.

D'Addabbo A, Palmieri O, Maglietta R, Latiano A, Mukherjee S, Annese V, Ancona N


2011; 12(): 166

RS-SNP: a random-set method for genome-wide association studies.

D'Addabbo A, Palmieri O, Latiano A, Annese V, Mukherjee S, Ancona N


2011; 186(7): 4027-38

Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.

Billmann-Born S, Till A, Arlt A, Lipinski S, Sina C, Latiano A, Annese V, Häsler R, Kerick M, Manke T, Seegert D, Hanidu A, Schäfer H, van Heel D, Li J, Schreiber S, Rosenstiel P


2011; ():

IL23R, ATG16L1, IRGM, OCTN1, and OCTN2 mRNA expression in inflamed and noninflamed mucosa of IBD patients.

Palmieri O, Latiano A, Scimeca D, Bossa F, Corritore G, Latiano T, Andriulli A, Annese V


2011; ():

Dissecting the mucosal expression of human leucine-rich repeat family genes in inflammatory bowel disease patients.

Palmieri O, Latiano A, Maglietta R, Palumbo O, Carella M, Ancona N, Bossa F, Andriulli A, Annese V


2011; ():

Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

Lastella P, Patruno M, Forte G, Montanaro A, Di Gregorio C, Sabbà C, Suppressa P, Piepoli A, Panza A, Andriulli A, Resta N, Stella A


2011; 7(1): e1001283

A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease.

Festen EA, Goyette P, Green T, Boucher G, Beauchamp C, Trynka G, Dubois PC, Lagacé C, Stokkers PC, Hommes DW, Barisani D, Palmieri O, Annese V, van Heel DA, Weersma RK, Daly MJ, Wijmenga C, Rioux JD


2011; 43(3): 246-52

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M,


2011; 140(2): 723-724

Reply

Scimeca D, Mocciaro F, Cottone M, Orlando A

2011; 7(1): e1001273

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology.

Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, International Inflammatory Bowel Disease Genetics Constortium, Cotsapas C, Daly MJ


2011; 43 Suppl 1(): S19-24

Hepatitis delta virus infection: open issues.

Niro GA, Gioffreda D, Fontana R


{accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

Altro in questa categoria: « Equipe Ricerca Corrente »

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube   g plus